Innovator Spotlight: Vertos Plans To Expand Reach Of Minimally Invasive Lumbar Decompression
Executive Summary
New professional consensus guidelines recommend Vertos Medical’s minimally invasive lumbar decompression (MILD) system as an alternative to epidural steroid injections for patients with lumbar stenosis. The company is planning to raise more capital to expand its commercial operation so it can reach more patients that could benefit from MILD.
You may also be interested in...
Medicare Slightly Expands Coverage For Spine Procedure, But Policy Remains Trial-Limited
Vertos Medical asked the US Medicare agency to reconsider its 2014 decision that limits coverage of percutaneous image-guided lumbar decompression for lumbar spine stenosis to certain clinical trials. The agency ruled Dec. 7 that it will stick with the trial-limited policy, but expanded it to include longitudinal studies.
National Academies Join Call For More Diversity In Trials
A new report from the National Academies of Sciences, Engineering, and Medicine issued a new report on the urgent need for better representation of underrepresented populations in clinical trials and research.
Boston Scientific Co-Founder Pete Nicholas Dies
Nicholas co-founded Boston Scientific in 1979 with John Abele. He served as the company’s CEO from 1979 until 1999 and as chairman until 2016.